IXEMPRA Drug Patent Profile
✉ Email this page to a colleague
When do Ixempra patents expire, and when can generic versions of Ixempra launch?
Ixempra is a drug marketed by R-pharm Us Llc and is included in one NDA.
The generic ingredient in IXEMPRA is ixabepilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ixabepilone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IXEMPRA?
- What are the global sales for IXEMPRA?
- What is Average Wholesale Price for IXEMPRA?
Summary for IXEMPRA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for IXEMPRA |
| What excipients (inactive ingredients) are in IXEMPRA? | IXEMPRA excipients list |
| DailyMed Link: | IXEMPRA at DailyMed |
US Patents and Regulatory Information for IXEMPRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
